TCT-566 Stent fracture is associated with a higher mortality in patients with type-2 diabetes treated by implantation of a second-generation drug-eluting stent

TCT-566 Stent fracture is associated with a higher mortality in patients with type-2 diabetes treated by implantation of a second-generation drug-eluting stent

The primary endpoints included the incidence of SF and a composite major adverse cardiac event [MACE, including myocardial infarction (MI), cardiac death, and target-vessel revascularization (TVR)] at 1-year follow-up and at the end of follow-up for overall patients, and target lesion failure [TLF,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-10, Vol.70 (18), p.B234-B235
Main Authors: Ge, Zhen, Kan, Jing, Zhang, Junjie, Li, Suiji, Tian, Nailiang, Ye, Fei, Qian, Xue-Song, Yang, Song, Rab, Tanveer, Chen, Shao-Liang
Format: Article
Language:eng
Subjects:
Diabetes
Diabetes mellitus
Drug delivery
Heart attacks
Implantation
Implants
Stents
Surgical implants
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The primary endpoints included the incidence of SF and a composite major adverse cardiac event [MACE, including myocardial infarction (MI), cardiac death, and target-vessel revascularization (TVR)] at 1-year follow-up and at the end of follow-up for overall patients, and target lesion failure [TLF, including cardiac death, target vessel myocardial infarction (TVMI) and target lesion revascularization (TLR)] at the end of study for SF patients. Conclusion Given the fact that diabetes is correlated with increased MACE rate, SF in diabetic patients translates into differences in mortality and re-repeat TLR compared with the non-diabetic group.
ISSN:0735-1097
1558-3597